Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.
Moffa S, Mezza T, Ferraro PM, Di Giuseppe G, Cefalo CMA, Cinti F, Impronta F, Capece U, Ciccarelli G, Mari A, Pontecorvi A, Giaccari A.
Moffa S, et al. Among authors: giaccari a.
Front Endocrinol (Lausanne). 2023 May 31;14:1124116. doi: 10.3389/fendo.2023.1124116. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37324254
Free PMC article.